About Scholar Rock

Scholar Rock is discovering and developing a pipeline of innovative new medicines to treat a range of serious diseases with high unmet medical need, including neuromuscular diseases, cancer and fibrosis.

By focusing on the newly elucidated biology of growth factor activation, Scholar Rock has developed new insights which allow us to selectively target growth factors in the disease microenvironment, to achieve therapeutic effects specifically at the source of disease. Our proprietary technology enables the development of innovative medicines that modulate the supracellular activation of growth factors in order to unlock the vast therapeutic potential of targeting growth factors to treat disease, and deliver new solutions for patients. Our most advanced product candidate, SRK-015, is being developed for the treatment of patients with Spinal Muscular Atrophy (SMA).

Scholar Rock is led by a highly-experienced management team of leaders who have built successful biotechnology companies, and is backed by leading investors.

CONTACT  |  SITEMAP  | 
 |  SITE DESIGN
“Scholar Rock” is a registered trademark of Scholar Rock, Inc.  |  © 2017 Scholar Rock All Rights Reserved.
Back to Top
 

The site you are about to visit is maintained by another organization, which is solely responsible for its content. As we cannot control the content or privacy practices of any third-party websites, we encourage you to read the privacy policy of every website you visit.

Continue   Cancel